{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T23:11:32Z","timestamp":1775085092755,"version":"3.50.1"},"reference-count":48,"publisher":"Oxford University Press (OUP)","issue":"966","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,4,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Limited data are available on the management of inflammatory bowel diseases (IBD) in East European countries. The diagnostic tools and most treatment options are also available in Eastern Europe. The diagnostic procedures commonly used became more sophisticated in the past few years, with a greater use of computed tomography\/magnetic resonance imaging and serology testing; however, double contrast barium enema, enteroclysis, and endoscopy remained standard. The medical therapy and surgical strategies are also somewhat different from those applied in Western countries. In ulcerative colitis, besides mesalazine, the use of sulphasalazine is still frequent, while azathioprine is only used in a minority of patients. The use of conventional corticosteroids is common and the rate of non-colorectal cancer associated colectomies is low. In contrast, 5-aminosalicylates are still used for maintenance in Crohn's disease and azathioprine is generally less frequently given compared with Western Europe. Biological agents have also become available about five years ago, yet their use is restricted mainly to specialised centres.<\/jats:p>","DOI":"10.1136\/pgmj.2005.043901","type":"journal-article","created":{"date-parts":[[2006,4,6]],"date-time":"2006-04-06T12:55:35Z","timestamp":1144328135000},"page":"270-273","source":"Crossref","is-referenced-by-count":10,"title":["Management of inflammatory bowel diseases in Eastern Europe"],"prefix":"10.1093","volume":"82","author":[{"given":"L","family":"Lakatos","sequence":"first","affiliation":[{"name":"1st Department of Medicine, Csolnoky F Province Hospital , Veszprem, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P L","family":"Lakatos","sequence":"additional","affiliation":[{"name":"1st Department of Medicine, Semmelweis University , Budapest, Hungary"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2006,4,5]]},"reference":[{"key":"2023042013585452100_bib1","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1053\/j.gastro.2004.03.075","article-title":"Editorial introduction","volume":"126","author":"Sartor","year":"2004","journal-title":"Gastroenterology"},{"issue":"suppl V","key":"2023042013585452100_bib2","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1136\/gut.2004.043372","article-title":"Guidelines for the management of inflammatory bowel disease in adults","volume":"53","author":"Carter","year":"2004","journal-title":"Gut"},{"key":"2023042013585452100_bib3","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1111\/j.1572-0241.2004.40036.x","article-title":"Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Commettee","volume":"99","author":"Kornbluth","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"2023042013585452100_bib4","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.3748\/wjg.v10.i16.2311","article-title":"Drug therapy for ulcerative coilitis","volume":"10","author":"Xu","year":"2004","journal-title":"World J Gastroenterol"},{"key":"2023042013585452100_bib5","article-title":"Is the incidence and prevalence of inflammatory bowel diseases increasing in Eastern Europe?","author":"Lakatos","journal-title":"Postgrad Med J"},{"key":"2023042013585452100_bib6","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1136\/pgmj.2003.013722","article-title":"Management of inflammatory bowel disease","volume":"80","author":"Nayar","year":"2004","journal-title":"Postgrad Med J"},{"issue":"suppl 170","key":"2023042013585452100_bib7","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3109\/00365528909091339","article-title":"Classification of inflammatory bowel disease","volume":"24","author":"Lennard-Jones","year":"1989","journal-title":"Scand J Gastroenterol"},{"key":"2023042013585452100_bib8","first-page":"2132","article-title":"Antineutrophil cytoplasmic antibodies in Estonian patients with inflammatory bowel disease. Prevalence and diagnostic role","volume":"45","author":"Kull","year":"1998","journal-title":"Hepatogastroenterol"},{"key":"2023042013585452100_bib9","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.3748\/wjg.v9.i10.2308","article-title":"Seroreactivity against Saccharomyces cerevisiae in patients with Crohn's disease and celiac disease","volume":"10","author":"Barta","year":"2003","journal-title":"World J Gastroenterol"},{"key":"2023042013585452100_bib10","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1006\/clim.2001.5145","article-title":"Antineutrophil cytoplasmic antibodies, anti-Saccharomyces cerevisiae antibodies, and specific IgE to food allergens in children with inflammatory bowel diseases","volume":"102","author":"Bartunkova","year":"2002","journal-title":"Clin Immunol"},{"key":"2023042013585452100_bib11","first-page":"22","article-title":"Assessment of usefulness of anti-Saccharomyces cerevisiae and anti-neutrophil cytoplasmic antibodies in patients with unspecific inflammatory bowel diseases","volume":"17","author":"Mokrowiecka","year":"2004","journal-title":"Pol Merkuriusz Lek"},{"key":"2023042013585452100_bib12","first-page":"131","article-title":"Initial experience with detection of Saccharomyces cerevisiae antibodies in patients with primary nonspecific inflammatory bowel disease","volume":"50","author":"Malickova","year":"2001","journal-title":"Epidemiol Mikrobiol Imunol"},{"key":"2023042013585452100_bib13","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.dld.2003.07.001","article-title":"Diagnostic role and clinical correlates of anti-Ssaccaromyces cervesiae antibodies (ASCA) and anti-neutrophil cytoplasmic antibodies (p-ANCA) in Italian patients with inflammatory bowel diseases","volume":"35","author":"Saibeni","year":"2003","journal-title":"Dig Liver Dis"},{"key":"2023042013585452100_bib14","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1111\/j.1572-0241.2005.00233.x","article-title":"Impact of race and ethnicity on inflammatory bowel diseases","volume":"100","author":"Basu","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"2023042013585452100_bib15","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1111\/j.1572-0241.2004.40486.x","article-title":"A prospective comparative study of ASCA and pANCA in Chinese and Caucasian IBD patients","volume":"99","author":"Lawrance","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"2023042013585452100_bib16","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.3748\/wjg.v11.i10.1489","article-title":"Toll-like receptor 4 and NOD2\/CARD15 mutations in Hungarian patients with Crohn disease: phenotype-genotype correlations","volume":"11","author":"Lakatos","year":"2005","journal-title":"World J Gastroenterol"},{"key":"2023042013585452100_bib17","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.3748\/wjg.v9.i10.2300","article-title":"Association of extraintestinal manifestations of inflammatory bowel disease (IBD) in a province of Western Hungary with disease phenotype: results of a 25-year follow-up study","volume":"9","author":"Lakatos","year":"2003","journal-title":"World J Gastroenterol"},{"key":"2023042013585452100_bib18","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1007\/s00108-002-0686-6","article-title":"Laboratory values, endoscopy and new imaging. What is the status of diagnosis?","volume":"43","author":"Herfarth","year":"2002","journal-title":"Internist"},{"key":"2023042013585452100_bib19","first-page":"2159","article-title":"Capsule endoscopy in small bowel diagnostics","volume":"144","author":"Racz","year":"2003","journal-title":"Orv Hetil"},{"key":"2023042013585452100_bib20","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1111\/j.1572-0241.2001.03749.x","article-title":"Clinical value of Technetium-99m-HMPAO-labeled leukocyte scintigraphy and spiral computed tomography in active Crohn's disease","volume":"96","author":"Molnar","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"2023042013585452100_bib21","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/01.MIB.0000160811.76729.d5","article-title":"Consensus conference: colorectal cancer screening and surveillance in inflammatory bowel disease","volume":"11","author":"Itzkowitz","year":"2005","journal-title":"Inflamm Bowel Dis"},{"key":"2023042013585452100_bib22","doi-asserted-by":"crossref","first-page":"v10","DOI":"10.1136\/gut.51.suppl_5.v10","article-title":"Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease","volume":"51","author":"Eaden","year":"2002","journal-title":"Gut"},{"key":"2023042013585452100_bib23","first-page":"175","article-title":"Risk factors for ulcerative colitis associated colorectal cancers in a Hungarian cohort of ulcerative colitis patients. Results of a population based study. (In Hungarian)","volume":"147","author":"Lakatos","year":"2006","journal-title":"Orv Hetil"},{"key":"2023042013585452100_bib24","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/gut.48.4.526","article-title":"The risk of colorectal cancer in ulcerative colitis: a meta-analysis","volume":"48","author":"Eaden","year":"2001","journal-title":"Gut"},{"key":"2023042013585452100_bib25","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/gut.26.1.43","article-title":"Incidence of colorectal carcinoma in pancolitis: a retrospective study of 959 cases over 40 years","volume":"26","author":"Maratka","year":"1985","journal-title":"Gut"},{"key":"2023042013585452100_bib26","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1097\/00042737-200312000-00004","article-title":"Prevalence and management of inflammatory bowel disease: a cross-sectional study from central England","volume":"15","author":"Stone","year":"2003","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2023042013585452100_bib27","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1053\/bega.2003.0361","article-title":"Crohn's disease: step up or top down therapy","volume":"17","author":"Hanauer","year":"2003","journal-title":"Best Practice Res"},{"key":"2023042013585452100_bib28","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1053\/j.gastro.2004.02.071","article-title":"Medical therapy for ulcerative colitis 2004","volume":"126","author":"Hanauer","year":"2004","journal-title":"Gastroenterology"},{"key":"2023042013585452100_bib29","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1056\/NEJM199406303302601","article-title":"Cyclosporine in severe ulcerative colitis refractory to steroid therapy","volume":"330","author":"Lichtiger","year":"1994","journal-title":"N Engl J Med"},{"key":"2023042013585452100_bib30","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S0016-5085(03)01214-9","article-title":"Randomized double blind comparison of 4 mg\/kg versus 2 mg\/kg intravenous cyclosporine in severe ulcerative colitis","volume":"125","author":"Van Assche","year":"2003","journal-title":"Gastroenterology"},{"key":"2023042013585452100_bib31","first-page":"443","article-title":"Medical treatment of inflammatory bowel diseases","volume":"21","author":"Van Assche","year":"2005","journal-title":"Curr Opin Gastroenterol"},{"key":"2023042013585452100_bib32","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1053\/j.gastro.2004.03.040","article-title":"Open questions concerning cyclosporine therapy in ulcerative colitis","volume":"126","author":"Molnar","year":"2004","journal-title":"Gastroenterology"},{"key":"2023042013585452100_bib33","first-page":"65","article-title":"Long-term efficacy of oral microemulsion cyclosporin for refractory ulcerative colitis","volume":"95","author":"Actis","year":"2005","journal-title":"Minerva Med"},{"key":"2023042013585452100_bib34","volume-title":"Cochrane Library","author":"McDonald","year":"2005"},{"key":"2023042013585452100_bib35","first-page":"745","article-title":"Retrospective analysis of case histories of patients with ulcerative colitis and Crohn's disease","volume":"39","author":"Zvirbliene","year":"2003","journal-title":"Medicina (Kaunas)"},{"issue":"suppl 4","key":"2023042013585452100_bib36","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1365-2036.2004.02056.x","article-title":"Review article: the management of mild to severe acute ulcerative colitis","volume":"20","author":"Travis","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"2023042013585452100_bib37","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00042737-200502000-00003","article-title":"Antibiotics for inflammatory bowel disease: do they work?","volume":"17","author":"Guslandi","year":"2005","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2023042013585452100_bib38","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1053\/gast.2002.34225","article-title":"Combined budesonide and antibiotic therapy for active Crohn's disease: a randomised, controlled trial","volume":"123","author":"Steinhart","year":"2002","journal-title":"Gastroenterology"},{"key":"2023042013585452100_bib39","volume-title":"Cochrane Library","author":"Akobeng","year":"2005"},{"key":"2023042013585452100_bib40","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1046\/j.1365-2036.2003.01793.x","article-title":"Antibiotics and azathioprine for the treatment of perianal fistulas in Crohn's disease","volume":"18","author":"Dejaco","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"2023042013585452100_bib41","first-page":"817","article-title":"Clinical presentation of Crohn's disease: Association between familial disease, smoking, disease phenotype, extraintestinal manifestations and need for surgery","volume":"52","author":"Lakatos","year":"2005","journal-title":"Hepatogastroenterology"},{"key":"2023042013585452100_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2036.2005.02520.x","article-title":"Review article: practical management of inflammatory bowel disease patients taking immunomodulators","volume":"22","author":"Siegel","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"2023042013585452100_bib43","volume-title":"Cochrane Library","author":"Alfadhli","year":"2005"},{"key":"2023042013585452100_bib44","first-page":"483","article-title":"First experiance with infliximab in Crohn's disease. Results from a multicenter study in Hungary","volume":"14","author":"Simon","year":"2004","journal-title":"LAM"},{"key":"2023042013585452100_bib45","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1056\/NEJMoa030815","article-title":"Infliximab maintenance therapy for fistulizing Crohn's disease","volume":"350","author":"Sands","year":"2004","journal-title":"N Engl J Med"},{"key":"2023042013585452100_bib46","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1055\/s-2005-869761","article-title":"Long-term management of resistant, fistulizing Crohn's disease by ongoing 4-weekly infliximab therapy","volume":"43","author":"Schwab","year":"2005","journal-title":"Z Gastroenterol"},{"key":"2023042013585452100_bib47","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1053\/j.gastro.2004.06.002","article-title":"Postoperative maintenance of Crohn's disease remission with 6-mercaptopurine, mesalamine, and placebo: a 2-year trial","volume":"127","author":"Hanauer","year":"2004","journal-title":"Gastroenterology"},{"key":"2023042013585452100_bib48","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.3748\/wjg.v11.i26.3971","article-title":"Factors affecting recurrence after surgery for Crohn's disease","volume":"11","author":"Yamamoto","year":"2005","journal-title":"World J Gastroenterol"}],"container-title":["Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/82\/966\/270\/50024314\/postgradmedj-82-270.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/82\/966\/270\/50024314\/postgradmedj-82-270.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T17:07:36Z","timestamp":1682010456000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pmj\/article\/82\/966\/270\/7045274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4,1]]},"references-count":48,"journal-issue":{"issue":"966","published-online":{"date-parts":[[2006,4,5]]},"published-print":{"date-parts":[[2006,4,1]]}},"URL":"https:\/\/doi.org\/10.1136\/pgmj.2005.043901","relation":{},"ISSN":["0032-5473","1469-0756"],"issn-type":[{"value":"0032-5473","type":"print"},{"value":"1469-0756","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2006,4]]},"published":{"date-parts":[[2006,4,1]]}}}